Showing results (21-30 of 69) with videos related to
Sort By:
Pageof 7
Diagnostic Pathology|May 4, 2017
Primary extragenital endometrial stromal sarcoma of the lung: first reported case and review of literatureLara Alessandrini, Francesco Sopracordevole, Giulio Bertola, et al.Pathology, Research and Practice|December 1, 2015
Morphologic shift associated with aberrant cytokeratin expression in a GIST patient after tyrosine kinase inhibitors therapy. A case report with a brief review of the literatureVincenzo Canzonieri, Daniela Gasparotto, Lara Alessandrini, et al.Genes, Chromosomes & Cancer|October 8, 2016
Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1Valentina Damiano, Giulia Brisotto, Silvia Borgna, et al.Oncotarget|July 16, 2014
Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signalingIlenia Segatto, Stefania Berton, Maura Sonego, et al.Journal of Advanced Research|August 9, 2025
Longitudinal prediction of drug response in high-grade serous ovarian cancer organoid cultures aligning with clinical responsesEnrico Cavarzerani, Isabella Caligiuri, Michele Bartoletti, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|May 6, 2020
Palladium(II)-η<sup>3</sup> -Allyl Complexes Bearing N-Trifluoromethyl N-Heterocyclic Carbenes: A New Generation of Anticancer Agents that Restrain the Growth of High-Grade Serous Ovarian Cancer TumoroidsThomas Scattolin, Enrica Bortolamiol, Fabiano Visentin, et al.Radiology Case Reports|May 16, 2022
Ultrasound detection of spontaneous rupture of accessory spleen: A case reportMarco Montanari, Pierpaolo De Ciantis, Andrea Boccatonda, et al.Cancers|October 31, 2020
Cancer Extracellular Vesicles: Next-Generation Diagnostic and Drug Delivery NanotoolsStefano Palazzolo, Lorenzo Memeo, Mohamad Hadla, et al.Breast (Edinburgh, Scotland)|January 29, 2013
Toxicity and cosmesis following partial breast irradiation consisting of 40 Gy in 10 daily fractionsMarco Trovo, Mario Roncadin, Jerry Polesel, et al.Current Cancer Drug Targets|December 1, 2017
Cancer Targeted Therapy Strategy: The Pathologist's PerspectivesLara Alessandrini, Tiziana Perin, Shahin Kadare, et al.Pageof 7